{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:39:37Z","timestamp":1787495977164,"version":"build-2736575974"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sintilimab-induced rash is a significant clinical challenge in lung cancer treatment, often necessitating therapy interruption or discontinuation and thereby compromising patient outcomes. The underlying mechanisms of this adverse event remain poorly understood. This study aimed to investigate potential predictive biomarkers and mechanisms of sintilimab-induced rash through metabolomic profiling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 55 patients with lung cancer who received sintilimab were enrolled, including 32 who developed rash and 23 matched controls without rash. Blood samples were collected before sintilimab infusion and at rash onset. Comprehensive clinical data were recorded. Untargeted metabolomic analysis of plasma was performed using ultra-high-performance liquid chromatography\u2013tandem mass spectrometry (UHPLC\u2013MS\/MS). Differential metabolites were identified and analyzed using pathway enrichment, univariate analysis (AUC \u22650.800), and SHAP analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant differences were observed between groups in demographic characteristics or most clinical parameters. However, the rash group exhibited significantly elevated total bile acids glucose (GLU), and basophil percentage (BAS%), along with reduced AST\/ALT ratio, alkaline phosphatase lactate dehydrogenase phosphorus (P), neutrophil count (NEU), and high-sensitivity C-reactive protein (hsCRP) (P &amp;lt; 0.05). Metabolomic analysis identified 92 differentially expressed metabolites. Pathway enrichment revealed alterations in oxytocin signaling, GnRH signaling, platelet activation, Fc\u03b3R-mediated phagocytosis, retrograde endocannabinoid signaling, pantothenate and CoA biosynthesis, Fc\u03b5RI signaling, and aldosterone synthesis and secretion. Univariate analysis identified 25 metabolites with high predictive value (AUC \u22650.800), and SHAP analysis highlighted 20 metabolites. Cross-comparison identified five overlapping metabolites: N,N,N-trimethyl-L-histidine, laurolactam, 2-naphthalenesulfonic acid, limonenecarboxylic acid, and N-lauroylsarcosine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Distinct clinical and metabolomic alterations are associated with sintilimab-induced rash in lung cancer patients. The identified differential metabolites may serve as predictive biomarkers and potential therapeutic targets, providing new insights for clinical management and mechanistic research into immune-related adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1846667","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:00:52Z","timestamp":1780466452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated metabolomics and machine learning identify predictive biomarkers via SHAP analysis for sintilimab-induced rash in lung cancer patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenxiu","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehe","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjuan","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University","place":["Wuxi, Jiangsu Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/cancers16091759","article-title":"Kinetics of IFN\u03b3-Induced cytokines and development of immune-related adverse events in patients receiving PD-(L)1 inhibitors","volume":"16","author":"Alserawan","year":"2024","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. Journal Medicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: A White Paper, community perspective","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics Official Journal Metabolomic Soc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/cod.13168","article-title":"Allergic contact dermatitis caused by hydroperoxides of limonene and dose-response relationship-A repeated open application test (ROAT) study","volume":"80","author":"Bennike","year":"2019","journal-title":"Contact Dermatitis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1021\/acs.chemrestox.3c00187","article-title":"Potential involvement of sulfotransferase in the mechanism of lamotrigine-induced skin rash","volume":"36","author":"Cao","year":"2023","journal-title":"Chem. Research Toxicology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. and Molecular Biology Letters"},{"key":"B7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Sci. (New York, N.Y.)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"122512","DOI":"10.1016\/j.jchromb.2020.122512","article-title":"Validation of a HPLC-UV method for the quantification of budesonide in skin layers","volume":"1164","author":"Demurtas","year":"2021","journal-title":"J. Chromatography. B, Anal. Technologies Biomedical Life Sciences"},{"key":"B9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jamaoncol.2020.0726","article-title":"Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer","volume":"6","author":"Dolladille","year":"2020","journal-title":"JAMA Oncology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat. Protocols"},{"key":"B11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1271\/bbb.80551","article-title":"High yield synthesis of 12-aminolauric acid by enzymatic transcrystallization of omega-laurolactam using omega-laurolactam hydrolase from acidovorax sp","volume":"73","author":"Fukuta","year":"2009","journal-title":"T31. Biosci. Biotechnology, Biochemistry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41392-023-01444-1","article-title":"Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury","volume":"8","author":"Gong","year":"2023","journal-title":"Signal Transduction Targeted Therapy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9283","DOI":"10.3390\/ijms24119283","article-title":"Unraveling membrane-disruptive properties of sodium lauroyl lactylate and its hydrolytic products: a QCM-D and EIS study","volume":"24","author":"Gooran","year":"2023","journal-title":"Int. Journal Molecular Sciences"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1080\/03007995.2024.2427323","article-title":"Enhancing immuno-oncology efficacy with H1-antihistamine in cancer therapy: a review of current research and findings","volume":"40","author":"Hamid","year":"2024","journal-title":"Curr. Medical Research Opinion"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1097\/HJH.0b013e32834a4c75","article-title":"Aldosterone as a modulator of immunity: implications in the organ damage","volume":"29","author":"Herrada","year":"2011","journal-title":"J. Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/circulationaha.122.060860","article-title":"NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload","volume":"147","author":"Higashikuni","year":"2023","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jid.2019.01.029","article-title":"Hyperglycemia is associated with psoriatic inflammation in both humans and mice","volume":"139","author":"Ikumi","year":"2019","journal-title":"J. Investigative Dermatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/jpet.112.200063","article-title":"Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes","volume":"344","author":"Inami","year":"2013","journal-title":"J. Pharmacology Experimental Therapeutics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Reviews. Mol. Cell Biology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/biom14030334","article-title":"Limonene exerts anti-inflammatory effect on LPS-induced jejunal injury in mice by inhibiting NF-\u03baB\/AP-1 pathway","volume":"14","author":"Kathem","year":"2024","journal-title":"Biomolecules"},{"key":"B21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpharm.2007.10.031","article-title":"Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol","volume":"352","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s12276-022-00725-z","article-title":"Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis","volume":"54","author":"Koh","year":"2022","journal-title":"Exp. and Molecular Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2014.02.035","article-title":"Ipilimumab in patients with cancer and the management of dermatologic adverse events","volume":"71","author":"Lacouture","year":"2014","journal-title":"J. Am. Acad. Dermatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/acs.jnatprod.1c00083","article-title":"Cannabidiol protects human skin keratinocytes from hydrogen-peroxide-induced oxidative stress via modulation of the Caspase-1-IL-1\u03b2 axis","volume":"84","author":"Liu","year":"2021","journal-title":"J. Nat. Prod."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2242211","DOI":"10.1080\/2162402x.2023.2242211","article-title":"Histamine antagonists promote cancer immunosurveillance","volume":"12","author":"Liu","year":"2023","journal-title":"Oncoimmunology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"eadj1431","DOI":"10.1126\/sciadv.adj1431","article-title":"(13)C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells","volume":"10","author":"Ma","year":"2024","journal-title":"Sci. Advances"},{"key":"B28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Reviews. Clin. Oncology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cells9040796","article-title":"The brain-skin connection and the pathogenesis of psoriasis: a review with a focus on the serotonergic system","volume":"9","author":"Martins","year":"2020","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/toxres\/tfaa008","article-title":"Bioaccumulation and toxicity of 2-naphthalene sulfonate: an intermediate compound used in textile industry","volume":"9","author":"Mehra","year":"2020","journal-title":"Toxicol. Research"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2350435","DOI":"10.1002\/eji.202350435","article-title":"The vitamin B5\/coenzyme A axis: a target for immunomodulation?","volume":"53","author":"Miallot","year":"2023","journal-title":"Eur. Journal Immunology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.redox.2020.101850","article-title":"The toxic side of one-carbon metabolism and epigenetics","volume":"40","author":"Morellato","year":"2021","journal-title":"Redox Biology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.1007\/s00216-015-9042-2","article-title":"Evaluation of changes induced in rice metabolome by Cd and Cu exposure using LC-MS with XCMS and MCR-ALS data analysis strategies","volume":"407","author":"Navarro-Reig","year":"2015","journal-title":"Anal. Bioanalytical Chemistry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","article-title":"Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke","volume":"9","author":"Nieswandt","year":"2011","journal-title":"J. Thrombosis Haemostasis JTH."},{"key":"B35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1523-1747.ep12319282","article-title":"Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption","volume":"109","author":"Nishijima","year":"1997","journal-title":"J. Investigative Dermatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Reviews. Mol. Cell Biology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1756284819870911","DOI":"10.1177\/1756284819870911","article-title":"Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities","volume":"12","author":"Pezo","year":"2019","journal-title":"Ther. Advances Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. Journal Medicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1242\/bio.017863","article-title":"Metabolomics reveals significant variations in metabolites and correlations regarding the maturation of walnuts (Juglans regia L.)","volume":"5","author":"Rao","year":"2016","journal-title":"Biol. Open"},{"key":"B40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40168-021-01221-8","article-title":"A multi-omics approach unravels metagenomic and metabolic alterations of a probiotic and synbiotic additive in rainbow trout (Oncorhynchus mykiss)","volume":"10","author":"Rasmussen","year":"2022","journal-title":"Microbiome"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2326-6066.Cir-22-0362","article-title":"Checkpoint blockade-induced dermatitis and colitis are dominated by tissue-resident memory T cells and Th1\/Tc1 cytokines","volume":"10","author":"Reschke","year":"2022","journal-title":"Cancer Immunology Research"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/metabo12121246","article-title":"Identification of D-Limonene metabolites by LC-HRMS: an exploratory metabolic switching approach in a mouse model of diet-induced obesity","volume":"12","author":"Rinaldi de Alvarenga","year":"2022","journal-title":"Metabolites"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/jco.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clinical Oncology Official Journal Am. Soc. Clin. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/s2352-3026(18)30192-3","article-title":"Safety and activity of sintilimab in patients with relapsed or refractory classical hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial","volume":"6","author":"Shi","year":"2019","journal-title":"Lancet. Haematol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/cac2.12385","article-title":"Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3)","volume":"42","author":"Shi","year":"2022","journal-title":"Cancer Communications Lond. Engl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am. Journal Clinical Dermatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","article-title":"Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses","volume":"14","author":"Th\u00e9venot","year":"2015","journal-title":"J. Proteome Research"},{"key":"B49","doi-asserted-by":"publisher","first-page":"bbad027","DOI":"10.1093\/bib\/bbad027","article-title":"Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM","volume":"24","author":"Tian","year":"","journal-title":"Brief. Bioinform"},{"key":"B50","doi-asserted-by":"publisher","first-page":"bbad346","DOI":"10.1093\/bib\/bbad346","article-title":"COIMMR: a computational framework to reveal the contribution of herbal ingredients against human cancer via immune microenvironment and metabolic reprogramming","volume":"24","author":"Tian","year":"","journal-title":"Brief. Bioinform"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2410285","DOI":"10.1002\/advs.202410285","article-title":"Network medicine-based strategy identifies maprotiline as a repurposable drug by inhibiting PD-L1 expression via targeting SPOP in cancer","volume":"12","author":"Tian","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.apsb.2024.08.017","article-title":"GSFM: a genome-scale functional module transformation to represent drug efficacy for in silico drug discovery","volume":"15","author":"Tian","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2026.02.004","article-title":"GEMap: a comprehensive gene essentiality map for drug discovery","volume":"16","author":"Tian","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. Journal Medicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1039\/d0cp05803c","article-title":"The oxidation mechanism of gas-phase ozonolysis of limonene in the atmosphere","volume":"23","author":"Wang","year":"2021","journal-title":"Phys. Chemistry Chemical Physics PCCP"},{"key":"B56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nprot.2012.135","article-title":"Global metabolic profiling of animal and human tissues via UPLC-MS","volume":"8","author":"Want","year":"2013","journal-title":"Nat. Protocols"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1071983","DOI":"10.3389\/fimmu.2023.1071983","article-title":"Cutaneous manifestations associated with immune checkpoint inhibitors","volume":"14","author":"Watanabe","year":"2023","journal-title":"Front. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.3390\/ijms22105229","article-title":"Roles of lipids in the permeability barriers of skin and oral mucosa","volume":"22","author":"Wertz","year":"2021","journal-title":"Int. Journal Molecular Sciences"},{"key":"B59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat. Reviews. Drug Discovery"},{"key":"B60","doi-asserted-by":"publisher","first-page":"27384","DOI":"10.1074\/jbc.M109.044065","article-title":"Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner","volume":"284","author":"Wong","year":"2009","journal-title":"J. Biological Chemistry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","article-title":"DS Wishart. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst","volume":"6","author":"Xia","year":"2011","journal-title":"Nat. Protocols"},{"key":"B62","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/ccid.S364243","article-title":"Skin manifestation induced by immune checkpoint inhibitors","volume":"15","author":"Yamamoto","year":"2022","journal-title":"Clin. Cosmetic Investigational Dermatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"949745","DOI":"10.3389\/fphar.2022.949745","article-title":"Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1\/PD-L1 immunotherapy","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.jtho.2020.07.014","article-title":"Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous NSCLC: a randomized, double-blind, phase 3 study (oncology pRogram by InnovENT anti-PD-1-11)","volume":"15","author":"Yang","year":"2020","journal-title":"J. Thoracic Oncology Official Publication Int. Assoc. Study Lung Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000536288","article-title":"Exploring immune-related adverse events: a case of febrile neutropenia in a melanoma patient receiving immunotherapy","volume":"17","author":"Yerolatsite","year":"2024","journal-title":"Case Reports Oncology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e64329","DOI":"10.3791\/64329","article-title":"Contact hypersensitivity as a murine model of allergic contact dermatitis","author":"Zemelka-Wiacek","year":"2022","journal-title":"J. Visualized Experiments"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/annonc\/mdx235","article-title":"Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg\/kg dosing regimen in patients with advanced tumors","volume":"28","author":"Zhao","year":"2017","journal-title":"Ann. Oncology Official Journal Eur. Soc. Med. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/jocd.16092","article-title":"The impacts of sodium lauroyl sarcosinate in facial cleanser on facial skin microbiome and lipidome","volume":"23","author":"Zhao","year":"2024","journal-title":"J. Cosmetic Dermatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jtho.2021.04.011","article-title":"Sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous NSCLC: results from a randomized, double-blind, phase 3 trial (ORIENT-12)","volume":"16","author":"Zhou","year":"2021","journal-title":"J. Thoracic Oncology Official Publication Int. Assoc. Study Lung Cancer"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1846667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:00:53Z","timestamp":1780466453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1846667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":69,"alternative-id":["10.3389\/fphar.2026.1846667"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1846667","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1846667"}}